86577541 - HEPTARES

Information

• Trademark
• 86577541

• Source

• Serial Number

  86577541

• Registration Number

  5239010

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  March 26, 2015
  9 years ago

• Registration Date

  July 11, 2017
  7 years ago

• Transaction Date

  July 05, 2024
  2 months ago

• Status Date

  January 02, 2024
  8 months ago

• Published for Opposition Date

  April 25, 2017
  7 years ago

• Location Date

  January 02, 2024
  8 months ago

• Status Code

  705

• Employee Name

  HUNT, LEE B

• Attorney Docket Number

  18634-570951

  Attorney Name

  Rebecca Liebowitz

  Law Office Assigned Location Code

  M60

• Owners

  • HEPTARES THERAPEUTICS LIMITED

Case File Statements

• GS0051: [ Biological products for medical purposes, namely, g-protein-coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, transmembrane proteins, G-Proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; none being dietetic substances adapted for medical use or food products ]
• TR0010: The wording "HEPTARES" has no meaning in a foreign language.
• GS0011: [ Chemicals and proteins used in research, namely, for chemistry and biological drug discovery, lead identification and diagnostics; proteins including G-protein-coupled receptors, trans-membrane proteins and parts thereof, for use in pharmaceutical research, namely, drug discovery purposes ]
• GS0441: Pharmaceutical advice; pharmaceutical consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes
• GS0421: Biotechnology testing, namely, genetic testing for scientific research purposes; Biotechnology research; Biotechnology development, namely, development in the field of drug discovery and biopharmaceuticals; biotechnology advice; Biotechnology consultancy; Biotechnology information, namely, providing information on the subject of scientific research in the field of biotechnology; Pharmaceutical testing; pharmaceutical research; pharmaceutical development; pharmaceutical consultancy for non-medical purposes; Providing medical and scientific research information in the fields of pharmaceuticals; scientific testing and research in the pharmaceutical and biopharmaceutical fields, namely, chemical and biological drug discovery services; providing scientific information, advice, and consultancy in the field of technologies related to proteins, including transmembrane proteins and G-proteins, and G protein coupled receptors, and parts thereof; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; Research and development in the pharmaceutical and biopharmaceutical fields, namely, technologies related to proteins and G protein coupled receptors; biology and chemistry services, namely, research and consulting in the field of chemistry and biology; pharmaceutical research services, namely, chemical and biological drug discovery services; research and development services for pharmaceutical lead identification; synthetic chemistry consultation services and research; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for non-medical screening purposes; research, analysis and identification of compounds through automated screening processes research and development services relating to pharmaceutical research services, namely, chemical and biological drug discovery services

Case File Event Statements

• 6/1/2015 - 9 years ago

  4 - ASSIGNED TO LIE Type: ALIE

• 3/30/2015 - 9 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 4/4/2015 - 9 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/27/2015 - 9 years ago

  3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 6/5/2015 - 9 years ago

  5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 6/29/2015 - 9 years ago

  6 - ASSIGNED TO EXAMINER Type: DOCK

• 7/12/2015 - 9 years ago

  7 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/12/2015 - 9 years ago

  8 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/12/2015 - 9 years ago

  9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 1/8/2016 - 8 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/15/2016 - 8 years ago

  11 - ASSIGNED TO LIE Type: ALIE

• 1/20/2016 - 8 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/20/2016 - 8 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/20/2016 - 8 years ago

  14 - REPORT UNRESPONSIVE AMENDMENT - COMPLETED Type: NAUD

• 1/20/2016 - 8 years ago

  15 - NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED Type: GAUD

• 1/20/2016 - 8 years ago

  16 - NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED Type: GAUN

• 2/16/2016 - 8 years ago

  17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/16/2016 - 8 years ago

  18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/16/2016 - 8 years ago

  19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/8/2016 - 8 years ago

  20 - FINAL REFUSAL WRITTEN Type: CNFR

• 3/8/2016 - 8 years ago

  21 - FINAL REFUSAL E-MAILED Type: GNFR

• 3/8/2016 - 8 years ago

  22 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 6/15/2016 - 8 years ago

  23 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 6/15/2016 - 8 years ago

  24 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/15/2016 - 8 years ago

  25 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/7/2016 - 8 years ago

  26 - SUBSEQUENT FINAL REFUSAL WRITTEN Type: CFRC

• 7/7/2016 - 8 years ago

  27 - SUBSEQUENT FINAL EMAILED Type: GNSF

• 7/7/2016 - 8 years ago

  28 - NOTIFICATION OF SUBSEQUENT FINAL EMAILED Type: GNS1

• 8/5/2016 - 8 years ago

  29 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/5/2016 - 8 years ago

  30 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/5/2016 - 8 years ago

  31 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/1/2017 - 7 years ago

  32 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/3/2017 - 7 years ago

  33 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/3/2017 - 7 years ago

  34 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/10/2017 - 7 years ago

  35 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/17/2017 - 7 years ago

  36 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 4/5/2017 - 7 years ago

  37 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/25/2017 - 7 years ago

  38 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/25/2017 - 7 years ago

  39 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/11/2017 - 7 years ago

  40 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 10/30/2018 - 5 years ago

  41 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 10/30/2018 - 5 years ago

  42 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 5/6/2020 - 4 years ago

  43 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 7/11/2022 - 2 years ago

  44 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 7/10/2023 - a year ago

  45 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 1/2/2024 - 8 months ago

  46 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 1/2/2024 - 8 months ago

  47 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P

• 1/2/2024 - 8 months ago

  48 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85

• 7/4/2024 - 2 months ago

  49 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN